Pharma ADMET Testing Market Share, Trends, and Analysis by 2028
Pharma ADMET Testing Market: Strategic Insights
Pharma ADMET Testing Market
-
CAGR (2021 - 2028)10.5% -
Market Size 2021
US$ 6.78 Billion -
Market Size 2028
US$ 13.58 Billion
Market Dynamics
GROWTH DRIVERS
- Increased demand for drug development
- Growth in pharmaceutical R&D investments
- Focus on reducing drug failure rates
FUTURE TRENDS
- Shift toward personalized medicine testing
- Development of high-throughput screening methods
- Focus on predictive toxicology
OPPORTUNITIES
- Adoption of AI in drug testing
- Growth in biologics and biosimilars testing
- Increasing outsourcing of ADMET testing
Key Players
- CMIC HOLDINGS Co LTD
- Charles River Laboratories
- Wuxi AppTec
- Promega Corporation
- MERCK KGaA
- Agilent Technologies Inc
- Biovia Dassault Syst mes
- Cyprotex Limited
- Bio Rad Laboratories Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Testing Type - In Vivo ADMET Testing
- In Vitro ADMET Testing
- In Silico ADMET Testing
Technology - Cell Culture
- High Throughput
- Molecular Imaging
- OMICS Technology
Application - Systemic Toxicity
- Renal Toxicity
- Hepatotoxicity
- Neurotoxicity
Get Free Sample For